Home / ABVC : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ABVC make money? Does ABVC have pricing power? What's the Earnings Whisper? Will ABVC profit more as the business scales? What is ABVC's management track record? Is ABVC's current price justified?

ABVC BioPharma, Inc.

$1.05 -$1.14 (-52.06%)

NASDAQ · 15 Sep 2026 13:53 UTC

Previous Close

Day Range

$1$1.06

Year Range

$0.71$3.4

Market Cap

27.3M

AVG Volume

132.19K

Trailing/Forward PE

-3.49/0.81

PEG ratio

0.03

Dividend Yield

Next Earnings Date

2026-11-16

Primary Exchange

NASDAQ

Revenue (USD)

ABVC Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	0
26 Q1	0
25 Q4	-795.95K
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	1.97K
24 Q3	389.28K
24 Q2	117.14K
24 Q1	1.21K

Net Income (USD)

ABVC Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-736.93K
26 Q1	-1.56M
25 Q4	-3.56M
25 Q3	-2.04M
25 Q2	-2.26M
25 Q1	-842.08K
24 Q4	229.3K
24 Q3	-394.77K
24 Q2	-942.34K
24 Q1	-2.83M

Operating Income (USD)

ABVC Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-779.53K
26 Q1	-1.57M
25 Q4	-2.99M
25 Q3	-1.96M
25 Q2	-2.29M
25 Q1	-693K
24 Q4	-334.16K
24 Q3	-302.32K
24 Q2	-860.11K
24 Q1	-2.84M

EBITDA (USD)

ABVC EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-755.86K
26 Q1	-1.55M
25 Q4	-3.57M
25 Q3	-1.96M
25 Q2	-2.1M
25 Q1	-607.27K
24 Q4	-30.09K
24 Q3	-160.29K
24 Q2	-836.9K
24 Q1	-2.64M

Cash Flows (USD)

ABVC Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	0
26 Q1	-894.24K
25 Q4	-1.42M
25 Q3	-133.26K
25 Q2	-894.17K
25 Q1	-539.83K
24 Q4	-493.61K
24 Q3	171.72K
24 Q2	-211.43K
24 Q1	-955.82K

EPS (USD)

ABVC EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0.03
26 Q1	-0.06
25 Q4	-0.15
25 Q3	-0.05
25 Q2	-0.13
25 Q1	-0.06
24 Q4	0.02
24 Q3	-0.02
24 Q2	-0.08
24 Q1	-0.29

Expenses (USD)

ABVC Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	282.07K
26 Q1	1.57M
25 Q4	2.2M
25 Q3	1.96M
25 Q2	2.29M
25 Q1	693K
24 Q4	336.12K
24 Q3	691.3K
24 Q2	984.58K
24 Q1	2.84M

Cash & Debt (USD)

ABVC Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	94.36K
26 Q1	202.51K
25 Q4	745.83K
25 Q3	257.24K
25 Q2	1.14M
25 Q1	824.62K
24 Q4	928.55K
24 Q3	840.68K
24 Q2	818.45K
24 Q1	734.92K

Debt ratios

ABVC Debt ratios by quarter
Period	Debt ratios
26 Q2	-0.21
26 Q1	-0.28
25 Q4	-0.33
25 Q3	-0.24
25 Q2	-0.4
25 Q1	-1.32
24 Q4	-0.62
24 Q3	-0.34
24 Q2	-0.25
24 Q1	-0.22

Margins

ABVC Margins by quarter
Period	Margins
25 Q4	100%
24 Q4	100%
24 Q3	99.92%
24 Q2	99.84%
24 Q1	77.01%
23 Q4	-6329.84%
23 Q3	-86.44%
23 Q2	-1094.65%
23 Q1	53.04%
22 Q4	54.94%

Return on Capital

ABVC Return on Capital by quarter
Period	Return on Capital
26 Q2	-6.01%
26 Q1	-12.16%
25 Q4	-26.79%
25 Q3	-14.09%
25 Q2	-23.78%
25 Q1	-10.58%
24 Q4	31.67%
24 Q3	-4.95%
24 Q2	-12.04%
24 Q1	-36.75%

Shares Outstanding

ABVC Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	26.06M
26 Q1	25.45M
25 Q4	23.26M
25 Q3	23.26M
25 Q2	17.39M
25 Q1	14.97M
24 Q4	13.32M
24 Q3	12.41M
24 Q2	11.32M
24 Q1	9.74M

Book Value Per Share (USD)

ABVC Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	0.47
26 Q1	0.5
25 Q4	0.57
25 Q3	0.62
25 Q2	0.55
25 Q1	0.53
24 Q4	0.05
24 Q3	0.64
24 Q2	0.69
24 Q1	0.79

Total Assets (USD)

ABVC Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	19.4M
26 Q1	19.73M
25 Q4	21.06M
25 Q3	21.18M
25 Q2	16.24M
25 Q1	14.88M
24 Q4	7.54M
24 Q3	14.46M
24 Q2	14.63M
24 Q1	14.69M

Employee Count

ABVC Employee Count by quarter
Period	Employee Count
2025	16
2024	16
2023	16
2022	19
2021	28
2020	30
2019	35
2018	38
2017	9
2016	9

Free Cash Flow Yield

ABVC Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-9.39%
Sep 26	-9.58%
Sep 26	-9.78%
Aug 26	-11.31%
Aug 26	-10.55%
Aug 26	-10.43%
Aug 26	-12.87%
Jul 26	-13%
Jul 26	-11.42%
Jul 26	-10.5%
Jul 26	-8.69%
Jul 26	-7.29%
Jun 26	-8.58%
Jun 26	-9.72%
Jun 26	-11.03%
Jun 26	-9.87%
May 26	-9.31%
May 26	-11.52%
May 26	-11.78%
May 26	-12.11%
May 26	-12.47%
Apr 26	-12%
Apr 26	-9.73%
Apr 26	-8.98%
Apr 26	-11.78%
Mar 26	-12.84%
Mar 26	-10.53%
Mar 26	-10.11%
Mar 26	-9.58%
Feb 26	-6.76%
Feb 26	-5.87%
Feb 26	-5.31%
Feb 26	-5.09%
Jan 26	-4.39%
Jan 26	-4.3%
Jan 26	-4.39%
Jan 26	-4.06%
Jan 26	-4.05%
Dec 25	-3.65%
Dec 25	-4.05%
Dec 25	-4.2%
Dec 25	-3.68%
Nov 25	-3.27%
Nov 25	-3.29%
Nov 25	-3.03%
Nov 25	-3.05%
Oct 25	-3.61%
Oct 25	-3.39%
Oct 25	-3.46%
Oct 25	-3.32%
Oct 25	-3.37%
Sep 25	-3.2%
Sep 25	-3.56%
Sep 25	-3.54%
Sep 25	-3.81%
Aug 25	-3.57%
Aug 25	-3.15%
Aug 25	-3.06%
Aug 25	-2.66%
Aug 25	-2.61%
Jul 25	-2.38%
Jul 25	-2.14%
Jul 25	-1.81%
Jul 25	-2.31%
Jun 25	-2.77%
Jun 25	-3.9%
Jun 25	-4.05%
Jun 25	-4.66%
May 25	-5.23%
May 25	-6.23%
May 25	-4.84%
May 25	-5.93%
May 25	-6.83%
Apr 25	-11.44%
Apr 25	-13.07%
Apr 25	-12.58%
Apr 25	-15.49%
Mar 25	-13.37%
Mar 25	-16.66%
Mar 25	-17.79%
Mar 25	-17.99%
Feb 25	-16.66%
Feb 25	-16.42%
Feb 25	-25.15%
Feb 25	-26.3%
Jan 25	-22.23%
Jan 25	-21.94%
Jan 25	-21.29%
Jan 25	-20.75%
Jan 25	-17.52%
Dec 24	-19.78%
Dec 24	-21.94%
Dec 24	-22.76%
Dec 24	-22.76%
Nov 24	-21.69%
Nov 24	-20.94%
Nov 24	-22.99%
Nov 24	-49.91%
Nov 24	-39.85%
Oct 24	-38.01%

Price to Sales

ABVC Price to Sales by quarter
Period	Price to Sales
Sep 26	-32.74
Sep 26	-32.09
Sep 26	-31.43
Aug 26	-27.17
Aug 26	-29.13
Aug 26	-29.46
Aug 26	-32.61
Jul 26	-32.29
Jul 26	-36.77
Jul 26	-39.97
Jul 26	-48.28
Jul 26	-57.55
Jun 26	-48.92
Jun 26	-43.16
Jun 26	-38.05
Jun 26	-42.52
May 26	-45.08
May 26	-36.45
May 26	-31.85
May 26	-30.97
May 26	-30.1
Apr 26	-31.26
Apr 26	-38.57
Apr 26	-41.78
Apr 26	-31.85
Mar 26	-29.22
Mar 26	-35.65
Mar 26	-37.11
Mar 26	-39.15
Feb 26	15496.51
Feb 26	17862.39
Feb 26	19755.09
Feb 26	20583.15
Jan 26	23895.38
Jan 26	24368.55
Jan 26	23895.38
Jan 26	25788.08
Jan 26	25906.37
Dec 25	28745.43
Dec 25	25906.37
Dec 25	24960.02
Dec 25	28508.84
Nov 25	32057.66
Nov 25	31821.07
Nov 25	34541.83
Nov 25	34423.54
Oct 25	124.43
Oct 25	132.43
Oct 25	129.76
Oct 25	135.1
Oct 25	133.32
Sep 25	140.43
Sep 25	126.21
Sep 25	126.65
Sep 25	117.76
Aug 25	125.76
Aug 25	142.65
Aug 25	146.65
Aug 25	79.5
Aug 25	80.97
Jul 25	88.62
Jul 25	98.63
Jul 25	116.89
Jul 25	91.57
Jun 25	76.26
Jun 25	54.17
Jun 25	52.11
Jun 25	45.34
May 25	40.34
May 25	33.86
May 25	43.58
May 25	35.63
May 25	30.91
Apr 25	25.54
Apr 25	22.35
Apr 25	22.24
Apr 25	18.06
Mar 25	20.93
Mar 25	16.79
Mar 25	15.72
Mar 25	15.55
Feb 25	16.79
Feb 25	17.03
Feb 25	11.12
Feb 25	10.63
Jan 25	12.58
Jan 25	12.75
Jan 25	13.14
Jan 25	13.48
Jan 25	15.96
Dec 24	14.14
Dec 24	12.75
Dec 24	12.29
Dec 24	12.29
Nov 24	12.9
Nov 24	13.36
Nov 24	12.17
Nov 24	43.74
Nov 24	54.78
Oct 24	57.44

Price to Book

ABVC Price to Book by quarter
Period	Price to Book
Sep 26	2.12
Sep 26	2.08
Sep 26	2.04
Aug 26	1.76
Aug 26	1.89
Aug 26	1.91
Aug 26	2.02
Jul 26	2
Jul 26	2.28
Jul 26	2.48
Jul 26	3
Jul 26	3.57
Jun 26	3.04
Jun 26	2.68
Jun 26	2.36
Jun 26	2.64
May 26	2.8
May 26	2.26
May 26	1.91
May 26	1.85
May 26	1.8
Apr 26	1.87
Apr 26	2.31
Apr 26	2.5
Apr 26	1.91
Mar 26	1.75
Mar 26	2.13
Mar 26	2.22
Mar 26	2.34
Feb 26	2.1
Feb 26	2.42
Feb 26	2.68
Feb 26	2.79
Jan 26	3.24
Jan 26	3.31
Jan 26	3.24
Jan 26	3.5
Jan 26	3.51
Dec 25	3.9
Dec 25	3.51
Dec 25	3.39
Dec 25	3.87
Nov 25	4.35
Nov 25	4.32
Nov 25	4.69
Nov 25	4.67
Oct 25	5.13
Oct 25	5.46
Oct 25	5.35
Oct 25	5.57
Oct 25	5.5
Sep 25	5.79
Sep 25	5.2
Sep 25	5.22
Sep 25	4.86
Aug 25	5.18
Aug 25	5.88
Aug 25	6.05
Aug 25	5.08
Aug 25	5.17
Jul 25	5.66
Jul 25	6.3
Jul 25	7.47
Jul 25	5.85
Jun 25	4.87
Jun 25	3.46
Jun 25	3.33
Jun 25	2.9
May 25	2.58
May 25	2.16
May 25	2.78
May 25	2.28
May 25	1.98
Apr 25	17.98
Apr 25	15.73
Apr 25	1.42
Apr 25	1.15
Mar 25	1.34
Mar 25	1.07
Mar 25	1
Mar 25	0.99
Feb 25	1.07
Feb 25	1.09
Feb 25	0.71
Feb 25	0.68
Jan 25	0.8
Jan 25	0.81
Jan 25	0.84
Jan 25	0.86
Jan 25	1.02
Dec 24	0.9
Dec 24	0.81
Dec 24	0.79
Dec 24	0.79
Nov 24	0.82
Nov 24	0.85
Nov 24	0.78
Nov 24	0.76
Nov 24	0.95
Oct 24	1

No video analysis for this stock yet. Request one from our team.

News: ABVC

defenseworld.net · 9 Sep 2026

Critical Survey: ABVC BioPharma (NASDAQ:ABVC) vs. Takeda Pharmaceutical (NYSE:TAK)

ABVC BioPharma (NASDAQ: ABVC - Get Free Report) and Takeda Pharmaceutical (NYSE: TAK - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, profitability and institutional ownership. Risk and Volatility ABVC BioPharma has a beta

AI Analysis

ABVC BioPharma, Inc.

Video analysis: ABVC

News: ABVC

Critical Survey: ABVC BioPharma (NASDAQ:ABVC) vs. Takeda Pharmaceutical (NYSE:TAK)

Similar companies